Serum alanine aminotransferase (ALT), a sensitive and simple indicator for liver injury in clinical practice [1], was demonstrated to be closely related to obesity [2], fatty liver [3], type 2 diabetes mellitus [4], and metabolic syndrome (MetS) [5–7] in recent decades. The gene discussed is GPT; the disease is type 2 diabetes mellitus.